Navigation Links
New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
Date:9/27/2007

Seven new hires are fruits of strategic plan

WATERTOWN, Mass., Sept. 27 /PRNewswire/ -- Beginning a new era of growth and discovery, Boston Biomedical Research Institute, an independent not-for- profit biomedical research institute located in Watertown, MA, has recruited seven new scientists, a 23% increase in its scientific staff.

The seven newly hired scientists are the fruits of a three-year strategic planning process designed to refine the Institute's basic research agenda into four core areas -- Cancer, Cardiovascular Disease, Regenerative Biology and Degenerative Disease, and Proteomics. "These core initiatives build upon the Institute's existing scientific strengths in protein-based basic research which uses disease models to find powerful new therapeutics for a range of illnesses, including cancer, Alzheimer's disease, stroke, and muscular dystrophy, among others," says Institute Director, Dr. Charles P. Emerson, Jr.

The new scientists include Dr. James L. Sherley who is studying adult stem cells with relevance to a range of problems associated with aging and how cancer forms; Dr. Shinichi Takayama who is researching a family of proteins known as BAG which plays a role in muscle degeneration and cancer, and is key to cell movement; Dr. Martin Duennwald and Dr. Moonkyoung Um and their collaborative research in the area of neurodegenerative diseases such as Alzheimer's, Parkinson's and Huntington's diseases; Dr. Oliver King who will begin a new program in computational biology at BBRI, and whose research involves understanding the evolution of proteins involved in neurodegenerative disorders; Dr. Kent Nybakken who is studying the function of a key signaling pathway, the Hedgehog pathway, which is important in normal development, stem cell regulation and cancer; and Dr. Sachiko Homma whose studies focus on sarcopenia, which is the loss of muscle mass that occurs with aging.

"By hiring new scientists in these key areas, the Institute is making a strong commitment to maximizing the potential for new collaborations that will ultimately lead to more significant and frequent discoveries," said board president, Mr. John R. Layton, "The Institute's ability to attract such talent is testament to the quality of science already underway here, and the new scientists recognize the benefits of the uniquely interactive environment for discovery that we actively foster."

In addition to attracting and developing new scientific talent, the Institute plans to broaden partnerships with laboratories at local universities and research institutes to further enhance its studies. "The selection of this impressive slate of scientists underscores BBRI's commitment to building successful collaborations both within and outside the Institute," said Dr. Emerson.

"The hiring of these exceptionally talented scientists will strengthen BBRI's efforts in conducting the most innovative research possible," said Dr. Judah Folkman, noted cancer researcher and Trustee of Boston Biomedical. "Under the leadership of Dr. Emerson, with his proven track record of innovation and his passion for disease-based research, this talented constellation of new scientific staff will enable BBRI to have an even greater impact on improving the health of people around the world."

"BBRI has emerged as a very innovative institution for collaborative disease research. The newly hired scientists possess a stellar combination of scientific brilliance, technical excellence, and collaborative savvy, and they are very enthusiastic about the unique research environment that BBRI provides," said Dr. Folkman. "These scientists promise to do great things for BBRI and for human health."

About Boston Biomedical Research Institute

Founded in 1968, Boston Biomedical Research Institute is a not-for-profit basic research institute dedicated to the understanding, treatment and prevention of a wide range of human diseases and conditions including cancer, cardiovascular diseases, neural and neuromuscular diseases, and degenerative diseases. For more information visit http://www.bbri.org

Media Contact: Elizabeth M. Erickson, 617-658-7707 or erickson@bbri.org


'/>"/>
SOURCE Boston Biomedical Research Institute
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. UW computer scientists fighting computer virus "Cold War"
2. Scientists find way to make human collagen in lab
3. Wisconsin scientists to be recognized for innovative biofuel technology
4. UW-Madison scientists to mimic nature for newest cancer drugs
5. UW scientists study strange material with communications potential
6. Scientists find nanotech method for examining cells
7. UW space scientists use Keck telescope to study wild weather of Uranus
8. UW computer scientists tout achievements and explain industry shortcomings
9. Facing shortage of U.S. scientists, UW wants to boost math enrollment
10. UW-Madison scientists find a key to cell division
11. TIP/UW Scientists Provide Mars Rover Commentary
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... CA (PRWEB) , ... May 04, 2016 , ... ... Well, look no further than LaJollaCooks4u, San Diego’s premiere hands-on cooking experience. Offering ... need to give mom an experience she won’t forget. , Guests that visit ...
(Date:5/4/2016)... ... ... Proove Biosciences, Inc. , the commercial and research leader in personalized pain ... partnership is designed to advance research in pain genetics in an effort to bring ... new agreement, researchers at Proove Biosciences are able to collaborate with Luda Diatechnko, MD, ...
(Date:5/4/2016)... , May 4, 2016  Bayer today ... oncology compound Stivarga ® (regorafenib) tablets for ... (HCC) has met its primary endpoint of a ... called RESORCE, evaluated the efficacy and safety of ... progressed after treatment with sorafenib. The safety and ...
(Date:5/4/2016)... New York, NY (PRWEB) , ... May 04, 2016 , ... ... neurofibromatosis (NF), a genetic disorder that causes tumors to grow on nerves throughout the ... treatment or cure. , Through numerous community events held during the month of May, ...
Breaking Biology Technology:
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a provider ... MegaMatcher Automated Biometric Identification System (ABIS) , ... multi-biometric projects. MegaMatcher ABIS can process multiple complex ... any combination of fingerprint, face or iris biometrics. ... SDK and MegaMatcher Accelerator , which ...
(Date:4/28/2016)... and BANGALORE, India , April 28, 2016 ... a product subsidiary of Infosys (NYSE: INFY ), ... a global partnership that will provide end customers ... mobile banking and payment services.      (Logo: ... innovation area for financial services, but it also plays a ...
(Date:4/28/2016)... GOTHENBURG, Sweden , April 28, 2016 ... 1,491.2 M (139.9), up 966% compared with the first quarter of ... Operating profit totaled SEK 589.1 M (loss: 18.8) and the operating ... SEK 7.12 (loss: 0.32) Cash flow from operations was ... , The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
Breaking Biology News(10 mins):